FutureX Capital and Tao Chang, founder of Dianping.com, led a USD120m Series C for China-based English learning platform Palfish, with follow-on from SIG and Whales Capital. Read more… Read More
SEAF has made an undisclosed investment in CloudCfo, a Philippines-based tech-enabled provider of outsourced accounting and financial services, through its Women’s Opportunity Fund. Read more… Read More
A1A Company led a USD32m investment in India-based healthtech Practo, with participation from Tencent, Sequoia Capital, Sofina Ventures, Matrix Partners, G Capital, and RTP Global. Read more… Read More
East Ventures, AC Ventures, and SMDV, the venture capital arm of the Sinar Mas Group, have invested USD5.5m in Indonesia-based fishery startup Aruna. Read more… Read More
Sequoia Capital India led a USD5m Series A for Eduvanz, an India-based education financing platform providing loans to individuals for skill development, with participation from existing investor Unitus Ventures. Read more… Read More
Faering Capital and Elevar Equity led a INR750m (approximately USD10m) Series C for WheelsEMI, an India-based non-banking finance company which offers loans for two-wheelers. Faering and Elevar Equity invested USD7.3m and USD2.7m, respectively. Read more… Read More
Go-Ventures and Northstar Group led an undisclosed Series B for Indonesia-based aquaculture startup eFishery, with participation from existing investors Aqua-spark and Wavemaker Partners. Read more… Read More
Real estate-focused private equity fund manager Gaw Capital Partners has reached a combined USD900m final close for two Asia-focused funds: The first vehicle will invest in real estate opportunities; the second vehicle will target education platforms and will partner with top-tier school operators through greenfield or brownfield developments,… Read More
Sequoia Capital India led a USD20m Series A for Singapore-based online invoice trading platform Incomlend, with participation from French shipping group CMA CGM. Read more… Read More
Hong Kong-listed Viva Biotech has agreed to acquire an 80% stake in China-based contract development manufacturing organization (CDMO) company Zhejiang Langhua Pharmaceutical for USD368m. The transaction, which is pending approval, will facilitate an exit for existing shareholders including Ninhua Group, Nuobai Investments, and Zhining Investments. Read more… Read More
(default archive template)